CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- SC 13G Stake Amended Statement of Ownership
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 563 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 1,929 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 507 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 547 shares (to pay taxes)
- 4 Grant or award CHIEF OPERATING OFFICER acquired 1,048 shares (grant or award)
- 4 Grant or award CHIEF ACCOUNTING OFFICER acquired 703 shares (grant or award)
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Results of operations · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Grant or award Director acquired 20,000 shares (grant or award)
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 24 of 39 · 778 filings